1984
DOI: 10.1111/j.1751-1097.1984.tb08871.x
|View full text |Cite
|
Sign up to set email alerts
|

HEMATOPORPHYRIN and HPD: PHOTOPHYSICS, PHOTOCHEMISTRY and PHOTOTHERAPY

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
116
0
1

Year Published

1986
1986
2003
2003

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 258 publications
(118 citation statements)
references
References 82 publications
1
116
0
1
Order By: Relevance
“…This is in accordance with early studies and recent reports on vascular constriction in connection with PDT (Selman et al, 1984;Kessel, 1984;Van der Veen et al, 1994;Roberts et al, 1994;Leveckis et al, 1995). A sharply decreased blood flow was also noticed by a gross examination immediately after the irradiation, as the treated area became darker as a result of the treatment.…”
Section: Discussionsupporting
confidence: 92%
“…This is in accordance with early studies and recent reports on vascular constriction in connection with PDT (Selman et al, 1984;Kessel, 1984;Van der Veen et al, 1994;Roberts et al, 1994;Leveckis et al, 1995). A sharply decreased blood flow was also noticed by a gross examination immediately after the irradiation, as the treated area became darker as a result of the treatment.…”
Section: Discussionsupporting
confidence: 92%
“…The most active component of hematoporphyrin derivative is thought to be the dihematoporphyrin ether [1,2] or ester [3] or even a triether/ester [4]. Hematoporphyrin derivative is selectively retained by malignant tumors [5][6][7], and excitation with red light (630 nm) results in the photodynamic destruction of the tumor tissue.…”
Section: Introductionmentioning
confidence: 99%
“…In addition to solid tumours, hairy-cell leukaemia and mycosis fungoides have also been treated with 8-methoxypsoralen and UVA (PUVA) (Honigsmann, 1987). The leading, most widely investigated, photosensitizers in PDT are the haematoporphyrins (HPDPhotofrin II) (Kessel, 1984), which were recently approved for clinical use. However, their use may be limited because of prolonged cutaneous phototoxicity, aggregation tendency, slow metabolism in vivo (Gomer, 1991;Grossweiner, 1994;Jones et al, 1996), as well as limited efficacies in affecting penetrating solid tumours (Orenstein et al, 1996).…”
mentioning
confidence: 99%